BIOMARIN PHARMACEUTICAL INC (BMRN) › RevenueBIOMARIN PHARMACEUTICAL INC (BMRN) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $1.12B2017: $1.31B2018: $1.49B2019: $1.70B2020: $1.86B2021: $1.85B2022: $2.10B2023: $2.42B2024: $2.85B2025: $3.22B$3.22B2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$3.22B+12.9%2024$2.85B+18.0%2023$2.42B+15.4%2022$2.10B+13.5%2021$1.85B-0.8%2020$1.86B+9.2%2019$1.70B+14.3%2018$1.49B+13.5%2017$1.31B+17.6%2016$1.12B—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share